The Initiative for Theranostics and Particle Therapy (ITPT) is a joint initiative of UW Carbone, UW School of Medicine and Public Health, Wisconsin Alumni Research Foundation and UW Health to strengthen existing research collaborations, create new partnerships and resources, and drive innovative treatments for metastatic cancer patients in Wisconsin and worldwide.
ITPT unites the efforts of researchers whose specialties include targeted radionuclide therapy (TRT) discovery and development, radiobiology, translational radiotherapy, medical physics, advanced imaging, personalized dosimetry, and radio-immunotherapy combinations. In addition to cross-training and educational goals, ITPT resources will support preclinical, translational and clinical research to advance new precision radiopharmaceutical development.
Featured ITPT Member Spotlights
Faculty Spotlight – Dr. Minglei Kang
Read the interview with Dr. Minglei Kang, Initiative for Theranostics & Particle Therapy Clinical Research & Practice Subcommittee Member
December 5, 2025
Upcoming ITPT Seminars
Thursday, February 26 2026 from 3-5pm – Stay tuned for registration details!
-
- Dr. Peter Caravan, Ph.D., Harvard Medical School
- Topic to come!
- Dr. Peter Caravan, Ph.D., Harvard Medical School
RASR Lab
ITPT oversees the Radiopharmaceutical Analytics and Specimen Research (RASR) laboratory. RASR enables UW Carbone researchers and external partners to store and analyze radioactive tissue samples and thoroughly examine the in vivo metabolism and biology of radiopharmaceuticals. The operational aim of the RASR is to harbor all radioactive analyses within the ITPT in order to streamline regulatory requirements and compliance while maximizing safety. RASR is a secure facility with access limited to approved researchers and staff. RASR equipment that enables state-of-the-art immunophenotyping of radioactive blood and tissues specimens. See full equipment list on their site.
Highlights from the 2025 ITPT Symposium
Our Newsletter
View Past ITPT Newsletters
Subscribe